UK approves Pfizer coronavirus pill

The Prime Minister of the United Kingdom, Boris Johnson, has claimed this Friday that the situation of the pandemic in the European country is “incomparably better” than last year, although he has reiterated his request for caution for the New Year holidays.

In a message to conclude the year, the British ‘premier’ has also warned about the “challenges” posed by the omicron variant of SARS-CoV-2 and the growing hospital pressure. Also, according to the BBC, has praised the “heroic” effort to vaccinate against COVID-19 in the United Kingdom, noting that all adults in England can now receive the booster dose if they wish.

Johnson’s words come at a time when British health authorities have notified infection records of COVID-19 and the United Kingdom Government once again scores a record of COVID-19 infections in full escalation of infections.

It imposed the return of telework or the obligation of the vaccination certificate to access certain facilities, measures provided for in what the Johnson Administration calls its’Plan B‘, which he presented in September in case the situation worsened. However, the Executive has already ruled out the possibility of imposing more limitations before 2022.

The Johnson Executive has trusted the development of the pandemic situation in the European country to the vaccination plan against COVID-19. Until this Friday, 82.4% of the British population has the complete immunization scheme, while 58.3% have already taken the third dose.

On the other hand, the UK regulatory authority has approved this Friday the use of the pill developed by Pfizer to treat COVID-19, Paxlovid.

As detailed by the Medicines and Health Products Regulatory Agency (MHRA), “Paxlovid stops the multiplication of the virus in cells and stops the multiplication process in the body”, which can help the body “to get over the viral infection“and” recover faster. “

The UK Ministry of Health has detailed that they have already been requested 2.75 million pills and that plans for its distribution will be revealed “soon.”

You may also like

Immediate Access Pro